Revenue: The sum of all revenue fields included for a company's operating activities.
Yubo International Biotech Limited (YBGJ) Revenue data is not available for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-0.44M |
|
-- |
|
-- |
|
$0.47M |
|
$-0.47M |
|
$0.00M |
|
$-0.47M |
|
$-0.47M |
|
$-0.47M |
|
$-0.47M |
|
$-0.47M |
|
$-0.47M |
|
$-0.47M |
|
$-0.42M |
|
119.82M |
|
119.82M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.69M |
|
$0.17M |
|
$0.48M |
|
$1.17M |
|
$4.78M |
|
-- |
|
$0.03M |
|
$4.81M |
|
$-3.65M |
|
$-3.69M |
|
$-3.65M |
|
119.82M |
|
| Cash Flow Statement Financials | |
$-0.39M |
|
$-0.01M |
|
$0.28M |
|
$0.01M |
|
$0.01M |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.40M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
12.82% |
|
12.65% |
|
-40.06% |
|
12.82% |
|
$-0.03 |
|
$-0.00 |
|
$-0.00 |
|